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Deubiquitylases (DUBs) regulate critical signaling
pathways at the intersection of host immunity and
viral pathogenesis. Although RIG-I activation is heavi-
ly dependent on ubiquitylation, systematic analyses
of DUBs that regulate this pathway have not been per-
formed. Using a ubiquitin C-terminal electrophile, we
profile DUBs that function during influenza A virus
(IAV) infection and isolate OTUB1 as a key regulator
of RIG-I-dependent antiviral responses. Upon infec-
tion, OTUB1 relocalizes from the nucleus tomitochon-
drial membranes together with RIG-I, viral PB2, and
NS1. Its expression depends on competing effects
of interferon stimulation and IAV-triggered degrada-
tion. OTUB1 activates RIG-I via a dual mechanism
of K48 polyubiquitin hydrolysis and formation of an
E2-repressive complex with UBCH5c. We reconsti-
tute this mechanism in a cell-free system comprising
[35S]IRF3, purified RIG-I, mitochondrial membranes,
and cytosol expressing OTUB1 variants. A range of
IAV NS1 proteins trigger proteasomal degradation
of OTUB1, antagonizing the RIG-I signaling cascade
and antiviral responses.
INTRODUCTION
Innate immunity against viral infections is triggered when germ-
line-encoded pattern recognition receptors (PRRs) sense the
presence of viral nucleic acids or other virus-specific compo-
nents. The retinoic acid-inducible gene I (RIG-I)-like receptor1570 Cell Reports 30, 1570–1584, February 4, 2020 ª 2020 The Auth
This is an open access article under the CC BY-NC-ND license (http://(RLR) family constitutes one such group of cytosolic PRRs that
is important in sensing viral RNA. Current evidence supports
the activity of threemembers of the RLR family: RIG-I, melanoma
differentiation-associated gene 5 (MDA-5), and laboratory of
genetics and physiology 2 (LGP2). RIG-I and MDA-5 detect a
wide range of RNA viruses and share several structural similar-
ities but often display differences in a cell-type- and virus-
strain-specificmanner (Jiang et al., 2012; Rehwinkel et al., 2010).
Many viral sensing and immune response mechanisms derive
from functional and structural studies of RIG-I (Yoneyama and
Fujita, 2008). Upon binding to double-stranded RNA (dsRNA),
RIG-I transforms from an auto-repressed to an open conforma-
tion (Kowalinski et al., 2011); this facilitates its tetramerization
and K63-linked ubiquitylation by either TRIM25 or RIPLET (Ca-
dena et al., 2019; Gack et al., 2007). RIG-I tetramers translocate
to mitochondrial membranes (Liu et al., 2012), where they
interact with mitochondrial antiviral signaling (MAVS) protein
via their respective CARD domains. The resulting complex re-
cruits downstream effector molecules (Gack, 2014; Pauli et al.,
2014; Zeng et al., 2010) and activates IRF3, IRF7, and nuclear
factor kB (NF-kB) to produce interferon-I (IFN-I), ultimately
creating an antiviral state.
Ubiquitylation, historically described for removal of misfolded
proteins, has emerged as a critical regulator for fine-tuning signal
transduction processes, and the RIG-I pathway is no exception.
Themode of RIG-I ubiquitylation and its implications on signaling
have been subjects of intense research in the past few years.
K63 ubiquitin chains, either in their free or conjugated forms,
are critical for RIG-I signal transduction. Until recently, K63 ubiq-
uitylation was thought to be catalyzed interchangeably by
TRIM25 and RIPLET; however, recent studies have indicated
that RIG-I activation is fundamentally dependent on RIPLET
(Cadena et al., 2019).or(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
All ubiquitin-dependent processes are accompanied by
an additional layer of regulation by deubiquitylases (DUBs)
(Komander et al., 2009). DUBs are an important class of en-
zymes, and many have been implicated in human diseases
(Reyes-Turcu et al., 2009). In immune signaling cascades, A20
(Catrysse et al., 2014), CYLD (Trompouki et al., 2003), OTULIN,
USP12, and Cezanne function as regulators in NF-kB and
T cell signaling (D€uwel et al., 2009; Jahan et al., 2016). Given
the essential role of ubiquitylation both upstream and down-
stream in the multi-step RIG-I signal cascade, it is very likely
that DUBs have key regulatory functions in this pathway. A few
have been implicated previously. USP21 is able to remove K63
chains from RIG-I (Fan et al., 2014), USP4 hydrolyzes K48
chains from transiently transfected RIG-I (Wang et al., 2013),
and OTUD1 facilitated degradation of MAVS by stabilizing an
E3-ligase (Zhang et al., 2018b).
In this study, we applied activity-based profiling (Ovaa et al.,
2004) to uncover DUBs that function during influenza A
virus (IAV) infection and identified OTUB1 as a critical regu-
lator of RIG-I activation. We established that OTUB1 is key
for optimal RIG-I signaling and functions via a coordinated
mechanism of hydrolyzing K48 chains and forming an E2-
repressive complex. Knockout of OTUB1 resulted in loss of
oligomeric RIG-I, disassembly of the signaling complex, and
failure of NF-kB and interferon regulatory factor (IRF) activa-
tion in IAV-infected cells. We recapitulated this phenomenon
in a reconstituted cell-free system to define the underlying
mechanism of OTUB1 function in this pathway. Hydrolysis
of K48 polyubiquitin chains and sequestration of UBCH5c
by OTUB1 were prerequisites for K63 polyubiquitylation of
RIG-I. Catalytically inactive OTUB1 displayed partial loss of
IRF3 dimerization; on the other hand, mutants that did not
form the E2-repressive complex or failed to relocalize to mito-
chondrial membranes abolished IRF3 activation. This phe-
nomenon was antagonized by IAV NS1, which triggered
proteasomal degradation of newly synthesized OTUB1.
Our results therefore provide fundamental insights into the
mechanism of maintaining fidelity and optimal magnitude
in the RIG-I signal transduction cascade and highlight the
complex interplay between immune responses and viral
antagonism.
RESULTS
Identification of Host DUBs Activated upon IAV Infection
Total cellular ubiquitylation profiles are often altered in IAV-in-
fected cells, depending on the severity of pathogenesis. To
establish whether this occurs in a strain-specific manner, we
detected bulk ubiquitylation in IAV-infected A549 cells ex-
pressing wild-type ubiquitin. K48-, K63-, and M1-linked ubiq-
uitylated proteins from mock- and virus-infected cells were
isolated by linkage-specific tandem ubiquitin-binding entities
(TUBEs). Although K48-linked ubiquitylation was consistently
lower in infected cells, K63-ubiquitylated species were more
pronounced in IAV-infected cells compared with mock-in-
fected cells. No significant changes were detectable in (M1)
linear chains between the different IAV strains; however, they
were elevated in infected cells compared with mock-infectedcells. Bulk profiles indicated distinct differences that exist in
the dynamics of ubiquitylation upon infection by different flu
viruses (Figure 1A).
To isolate DUBs from IAV-infected cells, we followed an exper-
imental setup as illustrated (Figure 1B; Jahan et al., 2016; Zhang
et al., 2018a) and applied previously to isolate cellular DUBs
(Jahan et al., 2016; Kwasna et al., 2018). Mock- and H1N1
pandemic IAV-infected primary lung epithelial cells or A549 cells
were permeabilized using perfringolysin O (Sanyal et al., 2012,
2013), and activated DUBs were isolated with ubiquitin-vinylme-
thylester (Ub-vme) carrying a TAMRA or hemagglutinin (HA) tag.
Ub-vme-reactive materials from control and infected cells were
resolved by SDS-PAGE and visualized by fluorescence scanning
(Figure 1C) or enriched on anti-HA beads first and detected by
silver staining (Figure 1D). Potential candidates were identified
by trypsin digestion, mass spectrometry, and spectral counting
of peptides on immunoprecipitated material (Table S1).
We validated the mass spectrometry (MS) hits in lysates pre-
pared from mock-infected, IAV-infected, or IFN-I-treated sam-
ples by immunoblotting and detected a shift in molecular
weight in proteins that reacted with Ub-vme (Figure 1E). Among
identified candidates were known regulators of IFN signaling
such as Usp25 (Lin et al., 2015), Usp15 (Pauli et al., 2014),
and DUBA, which displayed reduced expression in H1N1-
infected cells and high Ub-vme reactivity in IFN-I-treated sam-
ples, in agreement with a previous report (Kayagaki et al.,
2007).
OTUB1 Expression Is Induced by IFN-I and Degraded by
IAV
OTUB1 is a member of the ovarian tumor domain containing
a superfamily of proteases. It has a catalytic cysteine (C91),
several phosphorylation sites (phosphorylation on S16 can
determine cytosolic versus nuclear localization of OTUB1; Her-
haus et al., 2015), and hydrolyzes K48 ubiquitin chains (Edel-
mann et al., 2009; Juang et al., 2012; Figure 2A). It is also able
to inhibit ubiquitylation via its non-canonical activity of seques-
tering E2 enzymes (Juang et al., 2012).
OTUB1 expression levels increased as a function of time
and peaked 12 h after infection in multicycle IAV infections
(Figure 2B). This was followed by its degradation at later
time points, a phenomenon recapitulated in both A549 and
primary lung epithelial cells, with all IAV strains (Figures 2B
and 2C). To uncouple its induction from degradation, we per-
formed infections in Vero cells deficient in IFN production,
where IAV-dependent degradation of OTUB1 was more
apparent (Figure 2D). Vero cells treated with exogenous IFN-
b displayed a significant increase in the expression of
OTUB1, but not its degradation, suggesting that the latter
phenomenon was very likely virus mediated. Stimulation
with other ligands (lipopolysaccharide [LPS], poly(I:C)) did
not have a significant effect on OTUB1 protein levels in Vero
cells deficient in transcriptional induction of IFN-I (Figure 2D).
To further verify IFN-I-dependent induction of OTUB1,
we treated IFN receptor-proficient (IFNAR+/+) and deficient
(IFNAR/) cells with exogenous IFN-I. Induction of OTUB1
was specific to IFNAR+/+ cells (Figure 2E). To exclude NF-kB-
induced OTUB1 expression, we treated cells with Jsh-23, whichCell Reports 30, 1570–1584, February 4, 2020 1571
Figure 1. Identification of DUBs Activated upon IAV Infection
(A) Linkage-specific ubiquitylation profiles isolated frommock- and IAV-infected samples. A549 cells expressingWT ubiquitin were infected with different strains
of IAV (MOI 1.0, 10 h): A/PR/8/34, A/H1N1pdm09, and A/Oklahoma/309/06 (H3N2). Ubiquitylated proteins were isolated on linkage-specific tandem ubiquitin-
binding entities (TUBEs), resolved by SDS-PAGE, and detected by anti-ubiquitin antibodies.
(B) Schematic of isolation of DUBs activated upon IAV infection.
(C and D) 5 mMTAMRA-tagged (C) and 10 mMHA-tagged (D), Ub-vme-treated, mock- and IAV-infected primary epithelial cells. Ag-stained profiling of large-scale
immunoprecipitation (IP) of Ubvme-modified DUBs frommock- and IAV-infected cells was performed with 153 106 cells/condition. Entire lanes were sliced into
2-mm sections and subjected to MS/MS on an LTQ Orbitrap instrument for protein identification.
(E) Validation of identified proteins and their reactivity toward Ub-vme (5 mM) was performed in lysates prepared from IAV-infected (MOI 1.0, 10 h) or IFN-treated
(IFN-b, 200 IU/mL, 5 h) samples and verified by immunoblotting.blocks translocation of the p65 subunit from the cytosol to the
nucleus and subsequent expression of downstream genes.
Jsh-23 treatment restricted p65 distribution to cytosol fractions
in both H1N1-infected and IFN-I-treated cells (Figure 2F, top
panel). The expression profiles of OTUB1 however, remained
unaffected in lysates collected at the indicated time intervals
regardless of Jsh-23 treatment, suggesting that its induction oc-
curs independent of NF-kB activation (Figure 2E, bottom panel).1572 Cell Reports 30, 1570–1584, February 4, 2020OTUB1 Is Redistributed to Mitochondrial Membranes
and Co-segregates with RIG-I during Infection
To determine with what OTUB1 associates in IAV-infected cells,
we measured its localization by confocal imaging and neigh-
boring partners by proximity-based labeling. In uninfected cells,
OTUB1 resided largely in the nucleus; upon infection, it relocal-
ized from the nucleus to the cytosol and mitochondrial
membranes. A significant fraction colocalized with TOMM20, a
Figure 2. OTUB1 Is IFN Inducible and Degraded upon Influenza Infection
(A) Schematic of the domain architecture of OTUB1, showing its catalytic site, OTU domain, and ubiquitin binding domain (UBD)/E2-binding region, with specific
mutations in residues that were used in this study.
(B) Steady-state levels of OTUB1 in A549 cells infected with different strains of IAV (MOI 0.1) for the indicated time intervals. Zika virus (ZIKV) and vaccinia virus
(VACV) were used as controls (left panel). Lysates collected at the indicated time points after infection were immunoblotted with antibodies to endogenous
OTUB1. Densitometric analyses of protein expression were performed with ImageJ and normalized to 0 h. Curve fitting was performed with data from at least
three independent experiments (right panel).
(C) Steady-state levels of OTUB1 in primary lung epithelial cells stimulated with different viruses and assessed as in (B). Curve fits were generated with data from
at least 3 independent experiments.
(D) Steady-state levels of OTUB1 in Vero cells stimulated with either IAV or ligands alone; LPS was used to stimulate TLR4 and poly(I:C) for RIG-I. Samples were
process as in (B) and (C).
(E) WT and IFNAR/ HAP1 cells were treated with IFN-b (250 IU/mL) for the indicated time intervals. Lysates prepared from samples at each time point were
immunoblotted for expression of OTUB1.
(legend continued on next page)
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mitochondrial marker, specifically in infected cells but not in
mock-infected cells (Figure 3A). Phosphorylation-defective mu-
tants of OTUB1 (Herhaus et al., 2015), S16A (phospho-deficient)
and S16E (phosphomimetic), were enriched in the cytosol
and nucleus, respectively, whereas C91S, the catalytically
dead variant, and the D88A mutant, defective in binding E2
enzymes, displayed a similar intracellular distribution as that of
the wild type (Figure S1).
To identify its potential interactors in mock- and IAV-infected
cells, we first expressed a BioID-OTUB1 construct in the wild-
type (WT) or OTUB1/ background (Figure 3B) and cultured
cells in biotin-supplemented medium. Biotinylated proteins
were captured by streptavidin beads, resolved by SDS-PAGE,
and identified by LC-MS/MS (Figures 3C and 3D). Identified can-
didates were sorted by functional enrichment of pathways using
Ingenuity Pathway Analysis. The isolated candidates indicated
that OTUB1 preferentially associated with components of the
RIG-I signaling pathway in IAV-infected samples compared
with mock-infected samples, in which it primarily associated
with RNA helicases in the nucleus. Among the viral factors, we
identified PB2, as reported previously (Biquand et al., 2017),
and NS1. To confirm the MS data, we separated lysates from
mock- and IAV-infected cells by sedimentation on glycerol gra-
dients, where OTUB1 co-migrated with high-molecular-weight
RIG-I oligomers in IAV-infected but not in mock-infected cells
(Figure 3E). Interestingly, although IAV NS1 was distributed uni-
formly, PB2 displayed two peaks, one coinciding with that of
oligomeric RIG-I, which presumably corresponds to the mito-
chondrial fraction of PB2. These data suggest that OTUB1
is recruited to mitochondrial membranes along with active
RIG-I tetramers. As further validation, we isolated mitochon-
dria using a commercially available isolation kit, verified by
measuring enrichment of the respiratory chain components (total
OXPHOS complexes) (Figure 3F). In IAV-infected cells but not
mock-treated cells, myc-tagged RIG-I partitioned with the mito-
chondrion-enriched pellet (P) fractions. OTUB1 specifically co-
precipitated with this fraction of RIG-I, further confirming their
co-segregation at the mitochondrial membranes (Figure 3G).
OTUB1 Deletion Results in Defective NF-kB and IRF
Responses during RNA Virus Infection
To determine the functional effect of OTUB1 on RIG-I signaling,
we generated OTUB1/ A549 cells. Single clones selected after
serial dilution were expanded to verify deletion by immunoblot-
ting. WT OTUB1 was then reconstituted back into the deletion
background (rOTUB1) (Figure 4A, left panel). In parallel, we
generated OTUB1/ A549 cells expressing a dual reporter
for IRF and NF-kB activities (A549dual), measured via luciferase
and secreted alkaline phosphatase, respectively. OTUB1 was
deleted in either the WT or a RIG-I/ background in these re-
porter cells (Figure 4A, right panel).
Infection by RNA viruses and subsequent RIG-I signaling is
accompanied by activation of NF-kB and IRF3, which can be de-(F) A549 cells were left untreated or treated with 10 mM NF-kB inhibitor Jsh-23 an
(right panel).
(G) Densitometric analyses of protein expression in (E) and (F) were performedwith
three independent experiments.
1574 Cell Reports 30, 1570–1584, February 4, 2020tected by phosphorylation of the p65 subunit of NF-kB and
dimerization of IRF3. To monitor their activities in OTUB1/
and rOTUB1 cells, we measured the appearance of IRF3 dimers
and phosphorylated p65. In both instances, OTUB1 deficiency
resulted in loss of these activities, but they were rescued in
rOTUB1 cells (Figures 4B and 4C). Defective IRF3 activity was
also verified in primary lung epithelial cells upon small interfering
RNA (siRNA)-mediated depletion of OTUB1 (Figure S2D).
To establish how universal this effect was, we infected
A549dual cells (WT, OTUB1/, RIG I/, or OTUB1/RIG I/
double knockout) with different strains of IAV, Zika, encephalo-
myocarditis virus (EMCV), and a DNA virus (Vaccinia) in the sam-
ple set. Supernatants collected at different time intervals were
quantitated for NF-kB activity by measuring the absorbance of
secreted alkaline phosphatase at 620 nm. For all strains of influ-
enza as well as for poly(I:C) treatment, a significant reduction in
NF-kB activity was recorded in OTUB1/ cells, comparable
with RIG-I/ cells. No additive effect was noted in the double
knockout cells, suggesting that they most likely function in the
same pathway (Figures 4D and S2A). As with NF-kB activation,
OTUB1/ cells displayed significantly diminished IRF activity
upon infection with different strains of influenza as well as with
poly(I:C) (Figures 4E and S2A). On the other hand, OTUB1 defi-
ciency did not have any effect on LPS-dependent activation of
NF-kB or IRF (Figure S2B). Collectively, our results indicate
that OTUB1 deficiency inhibits NF-kB and IRF activities, sug-
gesting that it acts upstream of these transcription factors in
the RIG-I signaling cascade. OTUB1 deficiency had a partial ef-
fect on IRF activity with Zika virus too, which is sensed by both
RIG-I and MDA5 (Figure 4F); however, no effect was detected
with EMCV, which predominantly triggers MDA5 (Figure 4G).
Neither did it have any effect on STING activation with cyclic
2030-cGAMP (Figure 4H, I) or with Vaccinia infection because
the predominant virus sensing and immune activation to DNA
viruses is mediated by cGas/STING (Figure S2C).
The RIG-I Signaling Complex Disassembles in the
Absence of OTUB1
In uninfected cells, RIG-I remains folded with its CARD domains
in an auto-repressed inactive conformation. Upon infection, viral
dsRNA binding exposes the CARD domains, which interact with
K63 polyubiquitin chains and a multitude of effector molecules
for optimal signal transduction in the RIG-I-MAVS-TBK1-IRF3
axis (Figure 5A). To determine whether formation of the RIG-I
signaling complex requires OTUB1, we transduced myc-RIG-I
into RIG-I/A549 cells carrying a deletion of OTUB1 or express-
ing a WT copy and infected with H1N1(pdm). IFN-a production
was completely lost in OTUB1/ cells and rescued when recon-
stituted with WTOTUB1 but also partially in cells stably express-
ing myc-RIG-I, suggesting that compensatory mechanisms
might be activated in these cells (Figure S3B). Most of the
signaling molecules displayed enhanced expression in lysates
from IAV-infected cells compared with mock-infected cellsd infected with H1N1(pdm) at MOI 0.1 (left panel) or 100 IU/mL IFN-b for 12 h
ImageJ and normalized to 0 h. Curve fits were generatedwith data from at least
Figure 3. OTUB1 Is Distributed to the Cytosol and Mitochondrial Membranes upon Infection
(A) OTUB1 distribution (green) and TOMM20 (red) were visualized in mock-treated and IAV-infected samples (MOI 1.0, 8 h) using confocal imaging. Scale bars,
10 mm. Images are representative of more than 3 independent experiments. Pearson’s correlation coefficient was determined to quantitate colocalization of
OTUB1 and TOMM20 (right panel).
(B) Stable expression of the BioID-OTUB1 construct in either WT or OTUB1/ A549 cells was verified by immunoblotting.
(C) Ag-stained gel of immunoprecipitated material, captured on streptavidin beads, from mock- and IAV-infected A549 cells stably transduced with BioID-
OTUB1. 2-mm slices from entire lanes were processed and injected into a Lumos Orbitrap mass spectrometer for peptide identification.
(D) Spectral counts determined for candidates identified by MS were rank ordered with a threshold of 5-fold difference between mock and infected samples.
Significant hits were categorized into GeneOntology (GO) terms using Ingenuity Pathway Analysis. Two independent biological replicates from different cell types
(A549 and primary lung epithelial cells) were performed for MS analyses.
(E) Lysates prepared frommock- and IAV-infected cells were separated by velocity sedimentation on glycerol gradients (10%–40%); fractions collected from the
top were resolved by SDS-PAGE and detected by Ag staining (top panel). The migration characteristics of RIG-I, OTUB1, and IAV proteins NS1 and PB2 from
mock- and IAV-infected cells were determined by immunoblotting. HMW (high-molecular-weight) species and LMW (low-molecular-weight) species were
calibrated by internal markers.
(F) A549 cells were ruptured using a Dounce homogenizer, followed by mitochondrial isolation using the manufacturer’s protocol. Enrichment of mitochondria
was verified on 2 mg of total protein via western blotting with the MitoProfile Total OXPHOS detection kit.
(G) Mitochondrial fractions were isolated from mock- and H1N1-infected A549 cells expressing myc-RIG-I, as described in (F). Expression of total RIG-I
and OTUB1 was measured in lysates. IP of RIG-I was performed with anti-myc from the supernatant (S) and mitochondrion-enriched pellet (P) fractions.
Co-precipitation of OTUB1 in the corresponding fractions was measured by immunoblotting.(Figure 5B). Although all of them co-precipitated with myc-RIG-I
from cells expressing OTUB1 (either WT or reconstituted cells),
this failed in the absence of OTUB1 (Figure 5C, left panel). K63
polyubiquitin chains could also be captured with RIG-I in WT
cells or those reconstituted with OTUB1 but failed to co-purify
in OTUB1/ cells. We further investigated this complex by sedi-mentation over glycerol gradients. Lysates from IAV-infected
WT or OTUB1/ cells were separated by sedimentation over
10%–40% linear glycerol gradients. The collected fractions
were immunoblotted for RIG-I and associated partners. Most
of the signaling components co-migrated with high-molecular-
weight RIG-I in WT cells but not in OTUB1/ cells (Figure 5D).Cell Reports 30, 1570–1584, February 4, 2020 1575
Figure 4. OTUB1 Deficiency Blocks NF-kB and IRF Activation
(A) Clonal isolates of OTUB1 knockout generated by CRISPR/Cas9 and those reconstituted with WT OTUB1 in A549 cells; lysates were used for immunoblotting
(anti-OTUB1) to verify deletion and expression (left panel). Single clones of OTUB1-deleted A549 cells expressing a dual reporter for NF-kBand IRF activities were
generated that were either WT or deleted in RIG-I (right panel).
(B) Activation of IRF3 was measured in mock- and IAV-infected cells (either WT, OTUB1/, or reconstituted with WT OTUB1 [(rOTUB1]). IRF3 dimers were
resolved and detected by native PAGE.
(legend continued on next page)
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This effect also extended to MAVS oligomerization. Although its
expression was unaffected in OTUB1/ cells, multimerization of
MAVSwas abolished in OTUB1/ cells but rescued in those ex-
pressing WT OTUB1 (Figure 5E). These data indicate that, in the
absence of OTUB1, RIG-I fails to form active oligomeric struc-
tures, impeding recruitment of the signaling complex, MAVS
multimerization, and IRF3 dimerization. To exclude involvement
of OTUB1 downstream of MAVS in the RIG-I signaling cascade,
we transfected MAVS in OTUB1/ HEK293T cells in a dose-
dependent manner and exposed them to poly(I:C) treatment.
MAVS oligomers could form at very high concentrations even
in the absence of OTUB1 and were accompanied by IRF3 dimer-
ization, confirming that OTUB1 did not affect signaling down-
stream of MAVS oligomerization (Figure S3A).
In Vitro Reconstitution of OTUB1-Dependent IRF3
Dimerization Activity from Mitochondrial and Cytosolic
Fractions
OTUB1 belongs to the ovarian tumor (OTU) family of cysteine
proteases and specifically removes K48-linked polyubiquitin
chains (Edelmann et al., 2009; Wang et al., 2009). It also func-
tions non-catalytically by binding E2 enzymes that can either
inhibit ubiquitylation or stimulate K48 DUB activity, depending
on the concentration of free ubiquitin (Wiener et al., 2012). To
determine the mechanism of OTUB1-dependent regulation of
the RIG-I pathway, we reconstituted IRF3 dimerization in a
cell-free system composed of purified RIG-I, mitochondria,
[35S]IRF3, and cytosol preparations from cells expressing
OTUB1 variants (Figure 6A). RIG-I purified from either poly(I:C)-
treated or IAV-infected cells could support IRF3 dimerization
when incubated with cytosol and ATP (Figure 6B). Using this
assay, we tested different cytosolic preparations for their ability
to dimerize IRF3 (Figures 6C and 6D). Cytosol from OTUB1/
cells failed to induce IRF3 dimerization. Although cytosol ex-
pressing the WT or S16A (cytosolically enriched) could rescue
this defect, those expressing mutants defective in forming the
E2-repressive complex (D88A) or restricted to the nuclear frac-
tion (S16E) failed to induce IRF3 dimerization. Interestingly,
with the catalytically dead mutant C91S, there was only a partial
loss of IRF3 dimerization, suggesting that either the enzymatic
activity of OTUB1 is not required or that redundancy with other
cytosolic DUBs can partially compensate for this activity. Collec-
tively, these data indicate that the non-canonical function of
forming the E2-repressive complex rather than the enzymatic
activity of OTUB1 has a more profound effect on IRF3 activation.
To analyze this further, we performed time course analyses on
IRF3 dimerization with cytosol from OTUB1/ cells or from(C) Activation of NF-kB was measured in mock- and IAV-infected cells (WT, OTU
(D) Activation of NF-kB in A549dual cells (WT, OTUB1/, RIG-I/, or OTUB1/R
secreted alkaline phosphatase absorbance at 620 nm.
(E) Activation of IRF3 in cells (described in D) was measured by luciferase lumine
(F) NF-kB and IRF3 activities in ZIKV-infected cells (MOI 1.0) was measured at th
(G) NF-kB and IRF3 activities in EMCV-infected cells infected at MOI 1.0 for the
(H) A549dual cells were stimulated with 10 mg/mL of 2030-cGAMP. NF-kB induction
IRF induction was determined by QUANTI-Luc in a luminometer.
(I) Cells in (H) were stimulated with 10 mg/mL of linearized 2030-GAMP as a negat
All curve fits were generated with data from at least 3 independent experiments. T
replicates.those expressing its mutant variants. Rapid IRF3 dimerization
occurred with the WT and the S16A mutant, as noted above,
but not with the S16E and D88A mutant constructs. Cytosol ex-
pressing the catalytically dead C91S mutant displayed signifi-
cantly slower kinetics of IRF3 dimerization but was able to
partially support this activity at later time points (Figure 6E).
Collectively, our data indicate that formation of the E2OTUB1
repressive complex is a critical step in RIG-I-dependent IRF3 ac-
tivity. To validate these results in intact cells, we transduced
OTUB1/ A549 cells expressing the IRF luciferase reporter
with either the WT, C91S, or D88A constructs. These cells
were then stimulated with either poly(I:C) or infected with the
H1N1(pdm) strain. In line with our findings from the cell-free
in vitro assay, C91S was able to partially rescue IRF activity
whereas D88A did not (Figures 6F and 6G). Production of IFN-I
from these cells was also measured and reflected the phenotype
for IRF3 dimerization (Figure 6H).
To identify which E2 was being inhibited by OTUB1, we
tested UBC13 and UBCH5(a–c), all of which are known to
bind OTUB1. We generated a set of cytosolic preparations
from cells depleted in the corresponding E2s (Figure 6I) and
reconstituted them in the in vitro IRF3 dimerization assay.
Although UBC13-deficient cytosol was devoid of activity,
UBCH5c deficiency displayed even faster IRF3 dimerization
kinetics than that from WT cells (Figure 6J). These data reca-
pitulated OTUB1-dependent IRF3 activity and indicated that
formation of the UBCH5cOTUB1 repressive complex contrib-
utes to activating the RIG-I signaling pathway. However, we
cannot categorically rule out involvement of UBCH5a/b
because residual activities in the cytosol fractions could be
sufficient for ubiquitylation.
Our data suggest that OTUB1 prevents accumulation and
conjugation of K48 polyubiquitin chains to RIG-I. Therefore,
altering the local concentrations of K48 and K63 polyubiquitin
would, in principle, regulate association of RIG-I with K63 poly-
ubiquitin and subsequent IRF3 dimerization. To test this hypoth-
esis, cytosolic fractions from cells expressing WT OTUB1 were
supplemented with a defined concentration of ubiquitin contain-
ing either K63 alone (Ub2–Ub7) or varying ratios of K48:K63
chains to measure IRF3 dimerization. In line with our hypothesis,
increasing concentrations of K48 polyubiquitin resulted in a sys-
tematic reduction in the kinetics of IRF3 dimerization (Figure 6K).
At K48:K63 ratios of more than 2:1, the rate of IRF3 dimerization
decreased significantly, indicating that concentrations of
free polyubiquitin chains can determine optimal ubiquitylation
of RIG-I and regulate the magnitude of the signal transduction
cascade.B1/, or rOTUB1) by the appearance of phosphorylated p65.
IG-I/ double knockout) infected with different strains of IAV wasmeasured by
scence.
e indicated time intervals using the same readouts as in (D) and (E).
indicated time intervals and measured as in (D) and (E).
was determined by QUANTI-blue by measuring optical density (OD) at 620 nm;
ive control.
he images in (B) and (C) are representative of at least 3 independent biological
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Figure 5. Disassembly of the RIG-I Signaling Complex in the Absence of OTUB1
(A) Schematic of the activated RIG-I complex and known interactors of the pathway.
(B) A549 cells stably transduced with myc-RIG-I were genome edited to express either WT, OTUB1/, or rOTUB1 and exposed to mock or IAV infection.
Signalingmolecules were detected by immunoblotting in lysates prepared frommock- and IAV-infected cells (left panel); the presence of K63 polyubiquitin chains
in the lysates was measured using anti-K63 antibodies (right panel).
(C) IP of RIG-I using anti-myc from mock- and IAV-infected cells described in (B) was resolved by SDS-PAGE and immunoblotted for co-purifying components
(left panel) and K63 ubiquitin chains (right panel),
(D) Lysates fromWT or OTUB1/ cells infected with IAV was resolved by velocity sedimentation on glycerol gradients (10%–40% (w/v)); collected fractions were
desalted, resolved by SDS-PAGE, and detected by immunoblotting for components of the RIG-I complex.
(E) Lysates from (B) were also resolved by semidenaturing agarose gels (SDD-AGE) to visualize MAVS oligomerization in mock- and IAV-infected cells (top panel),
SDS-PAGE to measure total MAVS levels (center panel), and native PAGE to measure IRF3 dimerization (bottom panel).To detect RIG-IK63 association under the conditions
described above, we immunoprecipitated myc-RIG-I from
the reaction mix and immunoblotted with linkage-specific
anti-ubiquitin antibodies. The extent of co-precipitating
ubiquitin chains reflected those of the K48:K63 ratios and
downstream IRF3 activities (Figure 6L). Furthermore, for all
cytosol preparations that displayed attenuated IRF3 dimer-
ization, an increase in K48 polyubiquitin association with
RIG-I was noted compared with cytosol expressing WT
OTUB1 (Figure 6M). Our data indicate that high local concen-
trations of K63 polyubiquitin are maintained by OTUB1
activity to ensure optimal RIG-I-dependent immune
signaling. To validate OTUB1-dependent K48-linked ubiquity-
lation of RIG-I in intact cells, we co-transfected HA-
tagged ubiquitin with increasing plasmid concentrations
of OTUB1 in OTUB1/ HEK293T cells expressing myc-RIG-
I. A dose-dependent decrease in K48 polyubiquitin chains
co-precipitating with RIG-I was noted with increasing concen-
trations of OTUB1 (Figure S4).1578 Cell Reports 30, 1570–1584, February 4, 2020OTUB1 Is Targeted for Proteasomal Degradation by IAV
NS1
The reduction in steady-state levels of OTUB1 in IAV-infected
cells at later time points (Figures 2B–2D) suggested that it is
very likely targeted for degradation. Among the viral factors,
we identified PB2 and NS1 in the BioID assay (Figure 3D), both
of which are known to antagonize host immune responses
(Gack et al., 2009; Graef et al., 2010; Mibayashi et al., 2007).
We transfected PB2 and NS1 proteins of IAV to test which of
them mediated OTUB1 degradation. Expression of NS1 alone
was sufficient to reduce the steady-state levels of OTUB1 (Fig-
ure 7A). This was further validated by imaging viral NS1 and
OTUB1 in IAV-infected cells, which displayed mutually exclusive
expression characteristics (Figure 7B). To investigate the turn-
over of the newly synthesized pool of OTUB1, we first performed
pulse-chase assays in [35S]cysteine/methionine ([35S]cys/met)-
labeled cells expressing either the WT or C91S mutant of
OTUB1. Cells were infected with either WT PR8 IAV or its
recombinant mutant strains, one lacking NS1 (DNS1) and
Figure 6. In Vitro Reconstitution of OTUB1-Dependent IRF3 Dimerization
(A) Schematic for purification of cytosol and mitochondrial membranes for the reconstitution assay.
(B) IRF3 dimerization was reconstituted with myc-tagged RIG-I isolated from either IAV-infected or poly(I:C)-treated cells, purified with c-myc peptide, and
comparedwithmock-infected or untreated cells. The reactionmixture containedmitochondria, cytosolic extracts, ATP, [35S]IRF3, andRIG-I. Dimerization of IRF3
was analyzed by native gel electrophoresis after incubation for 120 min.
(C) Cytosolic extracts were prepared from OTUB1/ cells or reconstituted with WT, D88A, C91S, S16A, S16E mutants to test for their ability to induce IRF3
dimerization in the assay described in (B), with RIG-I isolated from poly(I:C)-treated cells.
(D) Same as (C), except RIG-I was isolated from IAV-infected cells.
(E) Time courses of IRF3 activation performed with cytosolic extracts as described in (C) and (D) using the assay described in (B). Quantitation of IRF3 dimers was
calculated as a percentage of the total from histogram plots generated by ImageJ densitometric analyses. Curve fitting was performedwith data obtained from at
least 3 independent experiments. Error bars represent mean ± S.D.
(legend continued on next page)
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another carrying a mutant NS1, lacking its effector domain
(mNS1). At the indicated time intervals, OTUB1 was immunopre-
cipitated and detected by autoradiography. Newly synthesized
WT OTUB1 underwent rapid degradation in the presence of
PR8 (WT) but not with either PR8 (DNS1) or mNS1. The stability
of catalytically dead OTUB1 (C91S), on the other hand, was not
affected despite equivalent expression of NS1 (Figure 7C). NS1-
dependent degradation of OTUB1 was also validated with the
H1N1(pdm) strain (Figure S5).
To further examine this effect, we transfected NS1 into cells
expressing OTUB1 variants and compared them with control
cells transfected with the empty vector. Both the WT and
cytosol-localized mutant (S16A) were rapidly degraded in the
presence of NS1, whereas the catalytic mutant (C91S) and that
deficient in binding to E2 (D88A) and nucleus localized (S16E)
remained unaffected (Figure 7D).
To test whether NS1-mediated degradation of OTUB1 was a
universal phenomenon, we expressed NS1 variants from
different strains of IAV. WT NS1 from PR8 was able to rapidly
degrade OTUB1, whereas a mutant lacking the effector
domain had no effect on OTUB1 turnover. Expression of
NS1 from all strains (H1N1(pdm), H3N2, and H9N2), except
H5N1, were able to degrade newly synthesized OTUB1
(Figure 7E). NS1-mediated degradation of OTUB1 was
blocked upon proteasomal inhibition by MG132 (Figure 7F).
Collectively, our data indicate that OTUB1-dependent activa-
tion of RIG-I is impeded by the presence of IAV NS1 by
facilitating its proteasomal degradation.
DISCUSSION
RLRs are critical cytosolic sensors for pathogen-associated
molecular patterns (PAMPs) and play key roles in prompting
innate immune responses against microbial infection. Virus
sensing triggers RIG-I tetramerization, K63 ubiquitylation, and
recruitment of signaling adaptor molecules, which culminate in
NF-kB and IRF activation to induce expression of antiviral genes.
Not surprisingly, during the course of their co-evolution, viruses
have acquired strategies to subvert such immune mechanisms
by various means, such as exploiting host factors to their own
advantage or triggering their degradation to dysregulate intracel-
lular processes.(F and G) OTUB1/ A549dual cells were reconstituted with either WT, C91S, or D8
for the indicated time intervals. IRF induction was determined by QUANTI-Luc in
(H) IFN production was measured from IAV-infected (H1N1(pdm), MOI 1.0) WT and
OTUB1/ background. Supernatants were collected at 24 h after infection and
(FACS) using a bead-based assay for cytokine detection. Error bars represent m
(I) The role of E2 enzymes in OTUB1-dependent IRF3 dimerization. Depletion of U
corresponding enzymes. Cell lysates were immunoblotted with antibodies again
(J) Cytosolic extracts generated from WT or OTUB1/ cells or from those depl
support IRF3 dimerization using the assay described in (E).
(K) Dependence of OTUB1-dependent IRF3 dimerization on the ratio of K48:K6
supplemented with either 10 mM K63 polyubiquitin (Ub2–Ub7) alone or with increa
total concentration of 10 mM.
(L) Polyubiquitylation status of RIG-I in the reaction mix was determined at the end
immunoblotting with linkage-specific anti-Ub.
(M) K48 polyubiquitin association with RIG-I was determined as in (L) in reactions
expressing cells.
1580 Cell Reports 30, 1570–1584, February 4, 2020Ubiquitylation is strategically positioned to fine-tune the
magnitude and duration of immune signaling cascades and,
therefore, is also an attractive target for viral subversion mecha-
nisms (Ribet and Cossart, 2010). In this study, we profiled
DUBs that are activated upon IAV infection and identified
OTUB1 as a critical regulator of RIG-I that is targeted for degra-
dation by IAV NS1. OTUB1 was IFN inducible, associated with
the RIG-I complex (specifically the active oligomeric pool at
the mitochondrial membranes), and targeted for proteasomal
degradation during IAV infection. Deletion of OTUB1 resulted
in impaired IRF3 and NF-kB activation equivalent to that of
RIG-I deletion with all tested strains of IAV and could be rescued
by reconstitution with the WT variant into the deletion
background.
To determine the mechanism of OTUB1-dependent RIG-I
activation, we adopted a cell-free system of IRF3 dimerization
(Zeng et al., 2010) reconstituted from purified RIG-I, mitochon-
dria, and cytosol expressing OTUB1 variants. Previous studies
have reported that OTUB1 specifically hydrolyses K48 polyubi-
quitin but also binds and sequesters E2 enzymes to inhibit
ubiquitylation (Herhaus et al., 2013; Sun et al., 2012). Mutation
in its catalytic cysteine (C91S) abolishes its enzymatic function.
The D88A mutation blocks its ability to bind to E2 enzymes
(Sun et al., 2012), and perturbation of its phosphorylation
alters it subcellular distribution; S16A is cytosolic, whereas
S16E is nucleus localized (Figure S1; Herhaus et al., 2015).
Cytosol fractions from cells deficient in OTUB1 did not support
IRF3 dimerization in the cell-free reconstituted assay. Among
cytosol preparations expressing the various mutants, WT
OTUB1 was proficient in supporting IRF3 activation, and C91S
displayed significantly slower kinetics, suggesting that this
activity is probably rescued by other cytosolic DUBs; however,
with the D88A mutant, IRF3 activity was completely blocked,
indicating that both the DUB activity and E2-repressive function
of OTUB1 are employed in the RIG-I signaling pathway.
To determine which E2s might function in this cascade, we
generated cells depleted of the known E2 interactors of
OTUB1, UBCH5(a–c), and UBC13. Depletion of UBC13, which
functions in TRIM25-dependent K63 ubiquitylation of RIG-I,
resulted in abrogation of IRF3 activity, whereas that of UBCH5c
in particular allowed rapid IRF3 dimerization, reminiscent
of OTUB1 rescue assays. Our data suggest that OTUB18A constructs of OTUB1 and stimulated with (F) poly(I:C) or (G) H1N1 (MOI 1.0)
a luminometer.
OTUB1/ A549 cells or those expressing either C91S or D88Amutants in the
secreted IFN-a was measured by ELISA or fluorescence-activated cell sorting
ean ± S.D. from at least three independent experiments.
BC13 and UBCH5(a–c) was performed in A549 cells using shRNA targeting the
st the endogenous proteins to confirm their depletion.
eted in the E2 enzymes from (I) were reconstituted to measure their ability to
3 ubiquitin chains. The reaction mixture in the IRF3 dimerization assay was
sing amounts of K48 polyubiquitin (Ub2–Ub7) to vary the ratio with a constant
point of IRF3 dimerization time courses in (K) by IP on anti-myc antibodies and
with cytosol preparations from WT, OTUB1/, D88A, C91S, and shUbch5c-
Figure 7. Influenza NS1 Triggers Proteasomal Degradation of OTUB1
(A) Steady-state levels of endogenous OTUB1 was measured in A549 cells transfected with either IAV NS1 or PB2.
(B) Expression of OTUB1 and IAV NS1 is anti-correlated. Confocal imaging was performed on cells infected with IAV (H1N1(pdm)). 8 h and 12 h after infection,
cells were fixed and stained to visualize distribution of OTUB1 and NS1. Scale bar, 10 mm. Images are representative of more than 3 independent experiments.
(C) WT OTUB1 but not the C91S catalytic mutant is degraded by IAV NS1. Pulse-chase analyses were performed with OTUB1/ cells expressing either
WT OTUB1 or C91S mutant and infected with either PR8 (WT), PR8 (DNS1), or PR8 (mNS1), which lacks the effector domain. Infected cells were pulsed with
[35S]cys/met and chased for the indicated time intervals. At each time point, OTUB1 (WT or C91S) was immunoprecipitated and detected by autoradiography.
The amount of remaining OTUB1 was calculated using densitometry as a percentage of total at the 0 time point, normalized to 100%. Expression of NS1 was
measured by IP on anti-NS1 antibodies, followed by autoradiography. Expression of PDI was measured as a loading control.
(D) OTUB1/ cells expressing either theWT ormutant variants were transfected with either empty vector (control [crtl]) or IAV NS1, and pulse-chase assays were
performed to measure OTUB1 turnover as described in (B).
(E) NS1 constructs from different IAV strains, as indicated, were transfected into cells for pulse-chase analyses as described in (B) and (C).
(F) NS1 from PR8 was transfected into cells expressing the WT or S16A variant of OTUB1 and left untreated or treated with 5 mM MG132 for 4 h to inhibit
proteasomal degradation. Pulse-chase analyses of OTUB1 turnover was determined as described in (B) and (C). Expression of PDI and NS1 wasmeasured by IP
on anti-PDI and anti-NS1 antibodies, followed by autoradiography.
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participates by a dual mechanism to enable RIG-I activation; first
via its conventional deubiquitylating activity and also by inhibi-
tion of E2 enzymes, most likely Ubch5c, although we cannot
exclude involvement of other E2s. This achieves two outcomes:
(1) it creates an optimal concentration of K63 polyubiquitin
chains, and (2) stabilizes and inhibits proteasomal degradation
of the RIG-I complex. The two distinct activities are likely regu-
lated by the local concentrations of K48 and K63 polyubiquitin
chains. A combined effect of hydrolyzing K48 chains and
inhibiting UBCH5c-mediated K48 ubiquitylation of RIG-I
would therefore provide tight regulation of RIG-I activation and
signal amplification upon infection. Not surprisingly, expression
of the multifunctional IAV NS1 alone was sufficient to downregu-
late this phenomenon through proteasomal degradation of
OTUB1. Interestingly, NS1-mediated degradation was specific
to WT OTUB1 but not the C91S catalytic mutant. This could
occur because of failure of NS1 interaction with OTUB1 (C91S)
or of the of the putative E3 ligases that recognize/ubiquitylate
OTUB1 (C91S). This study therefore underscores the intricate
and complex dynamic that exists in the utilization of DUBs in
the host-pathogen arms race. A mechanistic understanding of
its function in the context of infection provides fundamental
insights into regulation of cell signaling and viral evasion
strategies.STAR+METHODS
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Anti-OTUB1 Abcam Cat# ab175200
Anti-GAPDH Abcam Cat# ab8245; RRID:AB_2107448
Anti-NS1 Santa Cruz Cat# sc-130568; RRID:AB_2011757
Anti-PB2 Thermo fisher Scientific Cat# PA5-32220; RRID:AB_2549693
Anti-TRAF3 Abcam Cat# ab36988; RRID:AB_778570
Anti-UCHL3 Abcam Cat# ab126703; RRID:AB_11129956
Anti-USP3 Abcam Cat# ab101473; RRID:AB_10863008
Anti-DUBA Abcam Cat# ab176727
Anti-USP25 Abcam Cat# ab187156
Anti-HA-HRP Abcam Cat# ab128131; RRID:AB_11143947
Anti-RIG-I Abcam Cat# ab180675
Anti-ubiquitin Abcam Cat# ab7780; RRID:AB_306069
Anti-UB-K48 Abcam Cat# ab140601; RRID:AB_2783797
Anti-UB-K63 Abcam Cat# ab179434
Bacterial and Virus Strains
A/WSN/33 (H1N1) Sanyal et al., 2013 N/A
A/Oklahoma/309/06 (H3N2) Fan et al., 2017 N/A
A/Oklahoma/323/03 (H3N2) Fan et al., 2017 N/A
A/Hong Kong/1073/99 (H9N2) Chan et al., 2017 N/A
A/California/04/2009(H1N1) Poon et al., 2016 N/A
A/Puerto Rico/8/34 (PR/34) Garcı´a-Sastre et al., 1998 N/A
DNS1 A/Puerto Rico/8/34 (PR/34) Garcı´a-Sastre et al., 1998 N/A
Vaccinia virus wild-type Wyeth strain Valkenburg et al., 2014 N/A
EMCV ATCC VR-1479
ZIKV (NC-14-5132) ATCC VR-84
Chemocompetent E. coli DH5a Thermo fisher Scientific Cat# 18265017
Stbl3 bacteria Thermo fisher Scientific Cat# C737303
Chemicals, Peptides, and Recombinant Proteins
DMEM Sigma Aldrich Cat# D5523
HEPES Sigma Aldrich Cat# H3375
Protein A Sepharose 4B Thermo Fisher Scientific Cat# 101041
Blasticidin Invivogen Cat# ant-bl-05
Puromycin Invivogen Cat# ant-pr-1
Recombinant human Interferon (IFN)-b protein Sigma-Aldrich Cat# IF014
Lipopolysaccharides (LPS) Sigma-Aldrich Cat #L2762
Triton X-100 Sigma Aldrich Cat# 93443
10% Normal Goat Serum (NGS) Thermo Fisher Scientific Cat# 50062Z
Complete protease inhibitor cocktail Roche Cat# 138468
Protein A-agarose (IPA 300) RepliGen Cat# IPA300S
M270 streptavidin-coated Dynabeads Life Technologies Cat# 65305
Hygromycin B Roche Applied Science Cat# 10843555001
ProLong Gold Antifade Mountant Thermo Fisher Scientific Cat# P36930
MG132 Sigma Aldrich Cat#M7449
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Strep-Tactin beads IBA life sciences Cat# 2-4090-002
biotin Sigma Aldrich Cat# B4501
Dynabeads MyOne Streptavidin C1 Thermo Fisher Scientific Cat# 65001
TransITLT1 transfection reagent Mirus Cat#MIR2304
T4 Ligase NEB Cat# M0202S
Critical Commercial Assays
Ribomax T7 RNA polymerase kit Promega Cat# P2077
Renilla Luciferase Assay Promega Cat# E2820
MiniBEST Universal RNA Extraction Kit TAKARA Cat# 9767
Cytometric Bead Array assay (CBA) BD PharMingen Cat#560005
VeriKine Human Interferon Alpha Elisa Kit PBL Assay Science Cat# 41100-2
NE-PER Nuclear and Cytoplasmic Extraction Kit Thermo fisher scientific Cat# 78833
QUANTI-blue assay InvivoGen Cat# rep-qb1
QUANTI-Luc Gold assay InvivoGen Cat# rep-qlcg1
Experimental Models: Cell Lines
Vero E6 ATCC CRL-1586
MDCK ATCC CCL-34
A549 DUAL Invivogen N/A
A549 DUAL RIG-I Invivogen N/A
A549 DUAL OTUB1/ This study N/A
A549 DUAL RIG-I OTUB1/ This study N/A
293T ATCC CRL-3216
293T OTUB1/ This study N/A
A549 ATCC CCL-185
A549 OTUB1/ This study N/A
A549 Myc-birA-OTUB1 This study N/A
A549 OTUB1ovrexp This study N/A
A549 HA-birA- OTUB1 This study N/A
Primary human lung epithelial cells ATCC PCS-301-010
Oligonucleotides
GGGCTTCACTGAATTCACAA (sgRNA) This study N/A
Recombinant DNA
pSpCas9(BB)-2A-Puro (PX459) V2.0 Garcı´a-Sastre et al., 1998 Addgene plasmid # 62988)
OTUB1-PX459 This study N/A
pcDNA3.1 mycBio-ID Roux et al., 2012 Addgene plasmid #36047
pcDNA3.1 MCS-BirA(R118G)-HA Roux et al., 2012 Addgene plasmid #36047
BirA-OTUB1-HA This study N/A
BirA-OTUB1-MYC This study N/A
OTUB1 (C91S) This study N/A
OTUB1 (D88A) This study N/A
OTUB1 (S16A) This study N/A
OTUB1 (S16E) This study N/A
Myc-tagged RIG-I Te Velthuis et al., 2018 N/A
OTUB1-pOPINK Addgene Addgene plasmid #61420)
OTUB1*-pOPINB Addgene Addgene plasmid #65441)
pLenti6/V5-OTUB1 This study N/A
pLenti6/V5-DEST Zhang et al., 2018a Thermofisher plasmid # V49610
NS1 A/Puerto Rico/8/34 (PR/34) Hale et al., 2010 N/A
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NS1 A/California/04/09 NS1 (Cal/09) Hale et al., 2010 N/A
Strep-PB2 (from H1N1 WSN, H1N1 pdm09, H3N2) Biquand et al., 2017 N/A
pRK5-HA-Ubiquitin-K48 Addgene Addgene Plasmid 17605
HA-ub-K63 Addgene Addgene Plasmid 17606
HA-ubiquitin Addgene Addgene Plasmid 18712
Software and Algorithms
Prism 8.0 GraphPad Software https://www.graphpad.com/scientific-
software/prism/
ImageJ NIH https://imagej.net/ImageJ
ZEN confocal software Zeiss https://imagej.net/Fiji
CRISPR RGEN Tool Cas-OFFinder Cas-OFFinder http://www.rgenome.net/cas-offinder
RStudio 1.2.5001 RStudio, Inc https://rstudio.com
Ingenuity Pathway Analysis software QIAGEN https://www.qiagenbioinformatics.com/
products/ingenuity-pathway-analysis/LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests on reagents and resources should be directed to and will be fulfilled by the lead contact, Sumana
Sanyal (sanyal@hku.hk).
All unique/stable reagents generated in this study are available from the Lead Contact with a completed Materials Transfer
Agreement.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Lines
The following cell lines were used in this study: A549 cells (human; sex: male; ATCC-CCL-185), A549dual (human; sex: unspecified;
Invivogen a549d-nfis), HEK293T (human; sex: unspecified) and Vero E6 cells (Cercopithecus aethiops; sex: unspecified) were ob-
tained from commercial sources noted in the Key Resources Table and gender of the cell line was not a consideration in the study.
Cells were maintained in DMEM or EMEM supplemented with 10% FBS as specified by the manufacturer.
Primary cell cultures
Primary lung epithelial cells (human; sex: batch-specific; ATCC-PCS-300-010) were maintained according to the manufacturer’s
protocol.
Virus strains
The following virus strains were used in this study: Influenza A/WSN/33 (H1N1), A/Oklahoma/309/06 (H3N2), A/Oklahoma/
323/03 (H3N2), A/Hong Kong/1073/99 (H9N2), A/California/04/09 (H1N1 pandemic), A/Hong Kong/483/1997 (483/H5N1),
A/Puerto Rico/8/34 (PR/34), DNS1 A/Puerto Rico/8/34 (PR/34), Zika virus (NC-14-5132), Vaccinia (Wyeth) and EMCV. Influenza
viruses were propagated in Madin Darby canine kidney (MDCK) cells in minimum essential medium (MEM) supplemented with
0.3% bovine serum albumin (BSA) in the presence of 1 mg/ml tosylphenylalanyl chloromethyl ketone (TPCK)-treated trypsin
(Thermo Scientific), 1% (v/v) penicillin/streptomycin (Sigma-Aldrich). Supernatants from the virus cultures were harvested three
days post-infection. In order to maintain the homogeneity of the viruses, they were propagated with limited passage number and
seed stocks of viruses were prepared for future propagation. Virus stocks were aliquoted and stored at 80C. Viral titers were
calculated using plaque assays. ZIKV (NC-14-5132) and Vaccinia virus Wyeth strain were titrated by determining the tissue cul-
ture infective dose 50% (TCID50/ml) in Vero E6 cells challenged with 10-fold serial dilutions of infectious supernatants for 90 min
at 37C. EMCV was maintained according to the manufacturer’s protocol.
METHOD DETAILS
Virus infections
A549/ Vero/ 293T cells were seeded in 6-well plates with the seeding density of 0.8 X 106 cells per well one day before the experiment.
Cells were infected with viruses at a multiplicity of infection (MOI) of 4 (single cycle) or 0.01 (multi-cycle growth). After an hour ofCell Reports 30, 1570–1584.e1–e6, February 4, 2020 e3
adsorption, the viral inoculum was discarded, and infected cells were then washed with PBS and cultured in Opti-MEM added with
TPCK-treated trypsin (0.5-1 mg/ml) in a 37C incubator. Supernatants, cell lysates and RNA were harvested at indicated time points,
cleared by centrifugation and stored at 80C until ready to use.
RT-qPCR assay to measure virus infection
Total RNAwas extracted from cells usingminibest universal RNA extraction kit (Takara) according to themanufacturer’s manual. 1mg
of total RNA was used for the following reverse transcription assays. For the quantification of vRNA, 10 mM of vRNA specific primer
complementary to the 30 end of vRNA and 10 mM of b-actin specific primer complementary to the 30 end of b-actin gene was used
together with SuperScript III Reverse Transcriptase (Invitrogen); while for mRNAmeasurement 500 ng of oligo-dT primer was used in
another reverse transcription reaction. To determine the gene copy number of vRNA and mRNA from M gene, a SYBR Green based
real-time PCR method (Roche) was used, and the number of b-actin mRNA was used to normalize the total RNA concentration
between different samples. The PCR experiments were performed using the LightCycler system 480 (Roche). A reaction mix of
20 ml was composed of 1 ml of each gene-specific primer at 10 mM, 10 ml of SYBR Green master mix, 5 ml of 10-fold diluted cDNA
and 3 ml of distilled water. The amplification program was as it follows: 95C for 5 min, followed by 45 cycles of 95C for 10 s,
60C for 10 s and 72C for 10 s. The specificity of the assay was confirmed by melting-curve analysis at the end of the amplification
program. The primers for M gene and b-actin detection are described in the Key Resources Table.
Plaque assays
MDCK cells were seeded in 6-well plates with a seeding density of 1 X 10 6 per well. The following day confluent MDCK plates were
washed twice with PBS. 100 mL of 10-fold serial dilutions of supernatants were added to monolayers for adsorption. After one h of
incubation at 37C, the viral inoculum was discarded, and overlaid with MEM containing 1% agarose and 1 mg/mL TPCK-treated
trypsin, and incubated inverted at 37C for 3 days. Cells were fixed with 10% formalin in PBS overnight. and stained with 1% crystal
violet solution containing 20% ethanol. Plaques were counted and recorded after drying the plates.
Minigenome viral replicon assay
Cells were transfected in 12-well plates with plasmids encoding PB1, PB2, PA, and NP proteins (320 ng of NP, 160 ng [each] of PB1
and PB2, and 40 ng of PA), together with a plasmid expressing negative-sense firefly luciferase using the Lipofectamine 2000 trans-
fection reagent (Invitrogen), and incubated at 37C. Twenty hours after transfection, cells were lysed with 300 mL of passive lysis
buffer (Promega), and firefly luciferase activity was measured using a luminometer.
Screen for isolation of deubiquitylases
13 107 cells were detached from 10 cm dishes by brief trypsinization, washed once with Hank’s balanced salt solution (HBSS) and
resuspended in 100 ml (HBSS) on ice. PFO was added to cells to a final concentration of 100 nM and maintained on ice for 5 min. The
reaction mix was supplemented with an ATP regenerating mix, 10mMHA-Ubvme or TAMRA-Ubvme and protease inhibitor cocktail,
and transferred to 37C for 20 min. The reaction was terminated with lysis buffer. TAMRA-Ubvme reactive DUBs were resolved by
SDS-PAGE and visualized by fluorescence scanning, whereas HA-Ubvme labeled DUBs were first isolated on anti-HA beads,
resolved by SDS-PAGE and visualized by silver staining.
Immunoprecipitation and mass spectrometry
Large-scale immunoprecipitations were performed on conjugated HA-beads (for ubiquitylated substrates) and streptavidin beads
(for BioID). Entire lanes were sliced into 2 mm sections, and were further processed in 50% water/methanol. Samples were trypsi-
nized and subjected to a Lumos Orbitrap mass spectrometer for identification of candidates. MS/MS spectra were analyzed using
Sequest algorithm. The target sequences comprised the human protein repository of the Uniprot database and protein sequences
corresponding to the Influenza A PR8, WSN and H1N1 pandemic strains. Decoy sequences were obtained upon reversing the orien-
tation of target sequences. Allowed criteria for searches required trypsin cleavage (two missed cleavages allowed), peptide mass
tolerance of 20 p.p.m., variable oxidation of methionine residues, and static carbamylation modification of cysteine residues.
Peptide-spectrum matches were determined with estimated false discovery rate of 1%. Spectral counts for each condition were
combined at a protein level and normalized by protein length to infer protein abundances and intensities in each case. Identified
hits were further categorized into different biological pathways using Ingenuity Pathway Analysis software.
Isolation of OTUB1 partners in mock and virus infected cells
BioID assay
106 A549 cells expressing BirA-OTUB1 were cultured in media supplemented with 1mg/ml doxycycline and 50mMbiotin. Cells were
lysed in 1mL lysis buffer (50mMTris, pH 7.5, 150mMNaCl, 5mMEDTA, 1mMDTT, 0.5%TX-100 and 1X complete protease inhibitor
cocktail). Lysates were incubated with 500 ml of Neutravidin beads with end-over-end rotation for 1 hour at 4C. Bound material was
washed with buffer containing 0.5% TX-100 and eluted in 50 ml of Laemmli buffer saturated with biotin. 10% of the sample was
reserved for western blot analyses. Samples reserved for analyses by mass spectroscopy were washed with 50 mM NH4HCO3
before subjecting to protease digestion.e4 Cell Reports 30, 1570–1584.e1–e6, February 4, 2020
Quanti-blue SEAP Phosphatase assay
QUANTI-blue Gold is a two-component kit which contains: - QB reagent and – QB buffer, provided by Invivogen (HK). A standard
protocol according to manufacturer’s instructions was followed. The following protocol refers to the use of 96-well plates. 180 mL
of QUANTI-Blue Solution was dispensed per well into a flat-bottom 96-well plate. 20 mL of sample (supernatant of SEAP-expressing
cells) or negative control (cell culturemedium) were added and incubated at 37C for 15min to 6 h. Optical density (OD) at 620nmwas
measured using a microplate reader.
Quanti-luc luciferase assay
QUANTI-Luc Gold is a two-component reporter kit which contains: - QUANTI-Luc Plus and - QLC Stabilizer, provided by
Invivogen (HK). A standard protocol according to manufacturer’s instructions was followed. Quanta-Luc pouches were dis-
solved in sterile water together with QLC stabilizer. 20 ml of cell supernatant was added to a white opaque 96-well plate.
50 ml of QUANTI-Luc Gold assay solution was added to each well. The measurement was carried out immediately using a
luminometer.
Transient transfections and lentiviral transductions
Cells were transfected using either Fugene6 (Roche Diagnostics), TransIT or lipofectamine according to the manufacturer’s instruc-
tions. For generation of lentiviral particles, 293T cells were seeded at a density of 43 106 cells/dish (10 cm dishes) 24h before trans-
fection (in 12 mL of DMEM 10% FBS, 1% P/S, 1% HEPES). Transfection was carried out with TransIT reagent, following the man-
ufacturer’s instructions. Plasmids VSV-G, PLP1 (GAG/POL), PLP2 and plenti vector (plasmid of interest) were co-transfected with
TransIT reagent in Opti-MEM. 24h after transfection, the supernatant was removedwith a syringe, filtered on 0.22mmand stored over-
night at 80C. Virus particles collected from supernatants were concentrated by ultracentrifugation (28000 rpm, 4C). Pellets were
resuspended in 100 ml of PBS and left at 4C for 1h to resuspend the virus. A549 cells were seeded in 10 cm dish with a density of
4 3 106 cells/dish before lentiviral transduction. Transduction was performed using 30 ml of virus/dish (with dropwise distribution).
2 days after, the medium was changed and supplemented with 5 mg/ml of blasticidin. Medium was replaced every three days and
selection pressure was kept for two weeks, followed by single clonal expansions, which were verified with western blots for expres-
sion of desired protein.
Pulse-chase analysis of OTUB1 turnover
Pulse chase experiments were performed as previously described (Sanyal et al., 2013; Zhang et al., 2018a). Briefly, 1 3 107 cells,
eithermock or IAV-infectedwere detached by trypsinization and starved for 30min inmethionine/cysteine free DMEMat 37Cprior to
pulse labeling. Cells were labeled for 10 min at 37C with 10mCi/ml [35S]methionine/cysteine (expressed protein mix; PerkinElmer)
and chased for indicated time intervals. At appropriate time points, aliquots were withdrawn and the reaction was stopped with cold
PBS. Cell pellets were lysed in Tris buffer containing TX-100 and pre-cleared with agarose beads for 1 hour at 4C. Immunoprecip-
itations were performed for 3h at 4C with gentle agitation. Samples were eluted by boiling in reducing sample buffer, subjected to
SDS-PAGE and visualized by autoradiography.
Generation of knock-out and knock-down cells
CRISPR/Cas9 mediated deletion of OTUB1
Potential target sequence for CRISPR interference were found using the rules outlined elsewhere (Mali et al., 2013). Transfection of
recombinant plasmid into A549/ A549dual/ 293T cells was carried out using Trans-IT. After 24 hours, cells were subjected to puromy-
cin selection at a concentration of 3 mg/ml for A549 and 4 mg /ml for 293T. After 3 days, medium was replaced with that without pu-
romycin and selected cells were allowed to grow for 1-2 weeks depending on the number of surviving cells. Deletion efficiency was
checked in the mixed populations. For clonal expansion, selected cells were seeded in a 10 cm dish at a low density of 20 cells/dish.
Pyrex 8mm cloning cylinders were used to demarcate single colonies and silicone grease was used to create an isolated well.
Trypsinized colonies from isolated cylinders were grown in 12 well-plates and verified at passages 1, 3 and 10 for complete deletion
of OTUB1.
In vitro reconstitution of IRF3 dimerization
Biochemical assays for IRF3 activation with cytosolic extracts and mitochondrial preparations were as described previously
(Zeng et al., 2010). Briefly, hypotonic buffer [10 mM Tris-HCl (pH 7.5), 10 mM KCl, 1.5 mM MgCl2, 0.5 mM EGTA, and protease
inhibitor cocktail] was used to prepare cytosol fractions, and isotonic buffer (hypotonic buffer plus 0.25 M D-Mannitol) was used
to prepare mitochondrial membranes. Cells were homogenized in appropriate buffers, and centrifuged at 600 g for 5 minutes to
pellet nuclei. Post-nuclear supernatants were further centrifuged at 10,500 x g for 10 minutes to collect mitochondrial
membranes in the pellet fraction. Supernatants were subjected to centrifugation at 100,000 g, to separate cytosol fractions
from microsomes. Pelleted mitochondrial membranes were washed once with isotonic buffer. For IRF3 pathway activation
by RIG-I, the reaction mixture contained 1 mg/ml mitochondrial prep, 3 mg/ml cytosol fractions (from OTUB1-deficient cells
expressing OTUB1 variants), 1xMgATP buffer [20 mM HEPES-KOH (pH7.4), 2 mM ATP, 5 mM MgCl2], and [
35S]IRF3. After in-
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PAGE to visualize IRF3 dimerization by autoradiography using PhosphorImager (GE Healthcare). ImageQuant was used to
quantify signal intensity.
Glycerol gradient analyses
500 mL lysates frommock or infected cells was loaded onto a 3.8 mL glycerol gradient (10%–40% (w/v)) prepared in 1% (w/v) NP-40,
100 mM NaCl, 20 mM HEPES-NaOH pH 7.4. Sedimentation standards (ovalbumin (3.6S), BSA (4.2S), b-amylase (8.9S) and catalase
(11.4S)) were analyzed in a parallel gradient. The gradients were centrifuged in a BeckmanMLS 50 rotor at 35,000 rpm (165,000 gav)
for 20 h at 4C and fractions (300 ml) were collected from the top. The fractions collected were desalted on Bio-Gel P6 spin columns to
remove glycerol, resolved by SDS-PAGE and immunoblotted to visualize separation of RIG-I and OTUB1.
Immunofluorescence assays
For fluorescence microscopy, A549 cells were seeded the day before the experiment, on slides pre-coated with Poly-L- Lysine
(sigma). Seeding density used was 0.3 X 106 per well (in 12 well plates). Cells underwent infection with IAV or IFN type I treatment.
Time points were collected by washing the slides twice with PBS, followed by fixation with 4% formaldehyde for 20 minutes and in-
cubation in PBS at 4C. PBS with 0.05% Triton as permeabilization agent was used for 5 minutes followed by two washes with PBS
alone. The slides were blocked with either PBS + 4% FBS or PBS + 4% NGS, for 30min 1 hour at room temperature. Primary an-
tibodies at their appropriate dilution in PBSwas added and incubated for 2 hours at room temperature followed bywashing twicewith
PBS. Secondary antibodies diluted in PBSwas dispensed and incubated for 1 hour at room temperature. After twowashes with PBS,
the slides were stained with freshly diluted DAPI staining (sigma) for 2 minutes and rinsed twice with PBS. Slides were dried and
placed on glass slides overlaid with mounting buffer and kept overnight at 4C before visualizing with confocal microscopy.
QUANTIFICATION AND STATISTICAL ANALYSIS
Results generated for protein expression profiles and autoradiograms were analyzed by densitometry on ImageJ, from independent
biological replicates (where nR 3), each measured in technical duplicates or triplicates. Results have been presented as means ±
standard deviation (SD) for the specified number of experiments as described in the corresponding figure legends.
For image analyses of colocalization, Pearson’s correlation coefficients were calculated. For RT-qPCR, fold changes in mRNA
expression were determined using the DDCt method relative to the values in control samples as indicated in figure legends, after
normalization to housekeeping genes. Results obtained from luminescence, absorbance, RT-qPCR and plaque assays are pre-
sented as mean ± S.D, unless stated otherwise. Comparisons between two populations of data (e.g control and sample) were
made using the Student’s unpaired t test with a confidence limit for significance set at % 0.05. For multi sample comparisons,
two-way ANOVA was performed. All data generated were assumed to follow normal distribution and homogeneity of variance
based on Q-Q plots and Levene’s test. Statistical analyses were performed in GraphPad PRISM 8.0. and Bioconductor package
on RStudio. Pathway enrichment of hits from BioID assay was performed using Ingenuity Pathway Analysis software.
DATA AND CODE AVAILABILITY
The published article includes all the datasets generated or analyzed during this study, except the OTUB1-BioID interaction dataset
which is being used for a related manuscript under preparation, but is available from the corresponding author upon request.e6 Cell Reports 30, 1570–1584.e1–e6, February 4, 2020
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Accession 
no 
Protein name Mol 
mass 
(kDa) 
Unique peptides 
Mock     H1N1 
 
 
Mowse 
score 
No of 
MS/MS 
queries 
Seq 
coverage 
Q96FW1 Ubiquitin 
thioesterase protein 
OTUB1 
37 5 21 901 30 52 
Q9UHP3 Ubiquitin carboxyl-
terminal hydrolase 
25 
122 9 14 511 22 37 
Q96RU2 Ubiquitin carboxyl-
terminal hydrolase 
28 
122 6 14 285 5 28 
Q9Y614 Ubiquitin carboxyl-
terminal hydrolase 
3 
59 12 22 140 8 15 
Q92560 Ubiquitin carboxyl-
terminal hydrolase 
BAP1 
80 10 16 163 20 9 
Q13107 Ubiquitin carboxyl-
terminal hydrolase 
4 
108 28 8 57 4 12 
Q9Y5K5 Ubiquitin carboxyl-
terminal hydrolase 
isozyme L5 
38 13 31 177 5 10 
P15374 Ubiquitin carboxyl-
terminal hydrolase 
isozyme L3 
26 11 31 213 5 8 
Q96G74 OTU domain 
containing protein 5 
61 24 7 154 16 11 
Q7L8S5 OTU domain 
containing protein 
6A 
33 11 20 284 11 7 
Q9NQC7 Ubiquitin carboxyl-
terminal hydrolase 
CYLD 
107 12 34 41 4 5 
P21580 Tumor necrosis 
factor alpha-
induced protein 3 
90 6 18 58 2 6 
Q96DC9 Ubiquitin 
thioesterase 
OTUB2 
27 7 11 44 1 8 
Q9Y4E8 Ubiquitin carboxyl 
terminal hydrolase 
15 
112 10 19 31 3 10 
        
Table S1: Identification of deubiquitylases by HA-Ubvme in primary lung epithelial 
cells, either mock or H1N1 (pdm) infected. 
(Related to Figure 1)  
Figure S1: Subcellular distribution of OTUB1 mutant variants in IAV-infected 
cells (Related to Figure 3) 
OTUB1-/- A549 cells expressing the different variants of OTUB1 were generated by 
lentiviral transductions. C91S; catalytic mutant, D88A; deficient in binding to and 
forming the E2-repressive complex, S16A; phosphorylation deficient and expected to 
be enriched in the cytosol, S16E; phosphomimetic and expected to be enriched in 
the nucleus. Subcellular distribution of the panel of OTUB1 mutants were visualised 
by confocal imaging in IAV (H1N1 pdm) infected A549 cells expressing the OTUB1 
variants. Wild-type, C91S and S16A displayed a similar distribution – predominantly 
present in the cytosolic and mitochondrial compartments. D88A displayed a lack of 
distribution in the mitochondrial membranes whereas S16E remained confined to the 
nucleus upon IAV infection.  
 
 
Figure S2: NFkB and IRF3 activities in Poly I:C and LPS treated cells (Related to 
Figure 4) 
OTUB1 deletion was generated through CRISPR/Cas9 in A549 cells expressing 
reporters for NFkB and IRF activities measured via secreted alkaline phosphatase and 
luciferase respectively. OTUB1-/- cells were generated either in a wild-type 
background or those harboring a deletion of RIG-I to create a double knockout of 
OTUB1 and RIG-I. (A) The wild-type, OTUB1-/-, RIG-I-/-, and the double knock-out 
cells were treated with Poly I:C to stimulate the RIG-I  pathway. (B) LPS-treated 
samples were monitored as control. OTUB1-/- cells displayed attenuated NFkB and 
IRF activities, equivalent to that of RIG-I-/- and the double knock-out cells, when 
compared to the wild-type cells, when treated with poly I:C. On the other hand, 
activation of NFkB in LPS treated cells remained insensitive to deletions in OTUB1 or 
RIG-I or the combined deletion of the two. Since LPS does not trigger IRF activity, it 
remained at basal levels in all cells, upon LPS treatment. (C) NFkB and IRF3 activities 
in VACV-infected cells, infected at MOI 1.0 for indicated time intervals, and measured 
as described in Figure 4. (D) Primary lung epithelial cells were treated with non-
targeting (NT) scrambled siRNA and that against OTUB1. Depletion of OTUB1 was 
tested by immunoblotting (upper panel). Wild-type and OTUB1-depleted cells were 
mock-treated and infected with H1N1 (pdm) at MOI 1 for indicated time intervals. 
Lysates prepared were tested for IRF3 dimerisation using native gel electrophoresis 
(lower panel). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3: OTUB1 does not affect downstream of MAVS-dependent signaling 
(Related to Figure 5) 
 
(A) Lysates were generated from wild-type or OTUB1-/- HEK293T transfected with 
increasing plasmid concentrations of MAVS (5, 10, 50 and 100 µg/ml) and treated with 
poly I:C. Lysates were resolved either by (i) semi-denaturing agarose gels (SDD-AGE) 
to visualise MAVS oligomerisation in wild-type and OTUB1-/- cells (upper panel), or (ii) 
by denaturing SDS-PAGE to detect MAVS expression (middle panel), or (iii) by native-
PAGE to measure IRF3 dimerisation (lower panel). (B) Interferon production was 
measured from IAV-infected (H1N1 pdm, MOI 1) wild-type and OTUB1-/- A549 cells 
alongside cells reconstituted with either wild-type OTUB1 (rOTUB1), or myc-RIG-I in 
the OTUB1-/- background. Supernatants were collected at 24 hours post infection and 
secreted IFNa was measured either by ELISA, or FACS using a  bead based assay 
for cytokine detection. Error bars represent mean±s.d from atleast three independent 
experiments. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure S4: OTUB1 regulates ubiquitylation of RIG-I in H1N1-infected cells 
(Related to Figure 6). 
OTUB1-/- HEK293T cells were co-transfected with wt ubiquitin, myc-RIG-I and 
increasing concentrations of wild-type OTUB1. All samples were either mock-treated 
or infected with H1N1 (pdm) strain (MOI 1, 12 hours). For all the samples, RIG-I was 
immunoprecipitated on anti-myc and associated polyubiquitin chains were detect by 
immunoblotting with anti-Ub (upper panel). Expression levels of OTUB1 were 
measured in the corresponding lysates (lower panel). 
 
  
  
 
Figure S5: Influenza NS1 triggers proteasomal degradation of OTUB1 (Related 
to Figure 7). 
 
(A) Pulse-chase analyses were performed with OTUB1-/- cells expressing WT OTUB1, 
and infected with either H1N1 (pdm) (WT) or DNS1. Infected cells were pulsed with 
[35S]cysteine/methionine and chased for indicated time intervals. At each timepoint 
OTUB1 was immunoprecipitated and detected by autoradiography. NS1 was 
immunoprecipitated from the same samples to measuring expression at the indicated 
time intervals. PDI expression was measured as loading control. (B) Amount of 
OTUB1 remaining was calculated using densitometry as a percentage of total at the 
0 time point, normalised to 100%. Images are representative of atleast three 
independent experiments. 
